April 23, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY® Endovascular Robotic System, today announced the addition of two senior officers that ...

The latest price target for Microbot Medical (NASDAQ:MBOT) was reported by HC Wainwright & Co. on April 10, 2025. The analyst firm set a price target for $9.00 expecting MBOT to rise to within 12 ...

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.